Zivana Tezak
Overview
Explore the profile of Zivana Tezak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1940
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harris L, Shankar L, Hildebrandt C, Rubinstein W, Langlais K, Rodriguez H, et al.
J Natl Cancer Inst
. 2024 Jun;
116(10):1562-1570.
PMID: 38867688
The National Institutes of Health-US Food and Drug Administration Joint Leadership Council Next-Generation Sequencing and Radiomics Working Group was formed by the National Institutes of Health-Food and Drug Administration Joint...
2.
Duke E, Bradford D, Marcovitz M, Amatya A, Mishra-Kalyani P, Nguyen E, et al.
Clin Cancer Res
. 2023 Jun;
29(18):3573-3578.
PMID: 37265412
On September 21, 2022, the FDA granted accelerated approval to selpercatinib (Retevmo, Eli Lilly and Company) for the treatment of adult patients with locally advanced or metastatic solid tumors with...
3.
Fang L, Zhu B, Zhao Y, Chen W, Yang Z, Kerrigan L, et al.
Nat Biotechnol
. 2021 Sep;
39(9):1151-1160.
PMID: 34504347
The lack of samples for generating standardized DNA datasets for setting up a sequencing pipeline or benchmarking the performance of different algorithms limits the implementation and uptake of cancer genomics....
4.
Xiao W, Ren L, Chen Z, Fang L, Zhao Y, Lack J, et al.
Nat Biotechnol
. 2021 Sep;
39(9):1141-1150.
PMID: 34504346
Clinical applications of precision oncology require accurate tests that can distinguish true cancer-specific mutations from errors introduced at each step of next-generation sequencing (NGS). To date, no bulk sequencing study...
5.
Yoo S, Shi Z, Wen B, Kho S, Pan R, Feng H, et al.
Patterns (N Y)
. 2021 May;
2(5):100245.
PMID: 34036290
Sample mislabeling or misannotation has been a long-standing problem in scientific research, particularly prevalent in large-scale, multi-omic studies due to the complexity of multi-omic workflows. There exists an urgent need...
6.
Krusche P, Trigg L, Boutros P, Mason C, De La Vega F, Moore B, et al.
Nat Biotechnol
. 2019 Mar;
37(5):567.
PMID: 30899106
In the version of this article initially published online, two pairs of headings were switched with each other in Table 4: "Recall (PCR free)" was switched with "Recall (with PCR),"...
7.
Krusche P, Trigg L, Boutros P, Mason C, De La Vega F, Moore B, et al.
Nat Biotechnol
. 2019 Mar;
37(5):555-560.
PMID: 30858580
Standardized benchmarking approaches are required to assess the accuracy of variants called from sequence data. Although variant-calling tools and the metrics used to assess their performance continue to improve, important...
8.
Boja E, Tezak Z, Zhang B, Wang P, Johanson E, Hinton D, et al.
Nat Med
. 2018 Sep;
24(9):1301-1302.
PMID: 30194412
No abstract available.
9.
Tezak Z, Kondratovich M, Mansfield E
Per Med
. 2018 May;
7(5):517-530.
PMID: 29776248
Personalized medicine has captured the attention of the public, including patients, healthcare providers, scientists, medical product manufacturers and many others. The US FDA will evaluate many of the products that...
10.
Lubin I, Aziz N, Babb L, Ballinger D, Bisht H, Church D, et al.
J Mol Diagn
. 2017 Mar;
19(3):417-426.
PMID: 28315672
A national workgroup convened by the Centers for Disease Control and Prevention identified principles and made recommendations for standardizing the description of sequence data contained within the variant file generated...